Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
Cannabinoid-Based Drugs Seek New High, Part II
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Cell Line Validation in Biomanufacturing
Confirming Identity, Purity, Sterility, and Functionality of Cell Lines Helps Keep Patients Safe
For full access to this article login to GEN Select now.
Integral Molecular Sizes Up Ebola
Membrane Protein Specialist Maps Ebola’s Binding Sites to Advance Vaccine Discovery
- Ebola is the latest in a series of pathogenic viruses investigated by Integral Molecular, a research-oriented biotechnology company that has a sharp eye for viral membrane proteins. Before Integral Molecular turned its watchful gaze toward Ebola, the company kept tabs on chikungunya, hepatitis C, respiratory syncytial virus, and HIV. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.